
France: State responsible for jogger's toxic algae death
AI- Generated Image
A civil court in Nantes ruled Tuesday that the French government bore partial responsibility for the 2016 death of Jean-Rene Auffray, a 50-year-old jogger who suffered rapid pulmonary oedema, which sees the lungs fill with liquid, after he inhaled high concentrations of hydrogen sulfide on a beach in western Brittany.
In a statement, the court said that it "holds the state liable for negligence due to its failure to implement European and national regulations designed to protect waters from agricultural pollution," which is "the main cause of the proliferation of green algae in Brittany."
"For the first time, a French court has recognized the link between a person's death and the state's negligence in these green algae cases," said the family's lawyer, Francois Lafforgue.
Court overturns prior ruling in finding state liable
Auffray's family sued the French government for his sudden death but lost its case in 2022 when the presiding judge ruled there had not been enough evidence to directly link it to algae rotting on the Gouessant estuary near the city of Saint-Brieuc.
On Tuesday, the Nantes court ruled that the French state was 60% responsible for Auffray's death but also noted that he had put himself at risk by jogging in the area.
Auffray's widow will receive €277,343 ($321,750), while each of his three children will receive €15,000, and his brother €9,000.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất
IC Markets
Đăng ký
Undo
Brittany, the nation's pig farm
Brittany is a veritable agricultural powerhouse within France and is responsible for producing much of the country's dairy (one-third), poultry (one-half) and pork (one-third).
France has invested heavily in farming in the region for decades but that intensity and the excessive use of nitrate fertilizers combined with runoff from pig farms has led to massive algae bloom that chokes the coastal areas of the peninsula each year.
Deadly concentrations of sulfides released from the rotting stuff regularly close beaches in the region and cost French taxpayers millions as tons of algae are trucked off each summer.
France's top auditor reported in 2021 that an estimated 90% of Brittany's algae bloom could be traced back to farmers, who have significantly increased their use of nitrogen fertilizers since the 1960s.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Star Health to Outsource Claims Processing to Medi Assist's AI Platform
MUMBAI: In a first for India's largest retail health insurer, Star Health has decided to outsource a significant part of its claims operations to a third-party administrator. The insurer will adopt Medi Assist's AI-driven MAtrix platform to expedite claims processing and enhance fraud detection capabilities. The move is part of Star Health's broader effort to modernize its claims ecosystem. The platform, which uses intelligent automation and real-time data integration, will eventually handle the full volume of Star Health's in-house claims portfolio. According to Medi Assist, the AI tools embedded in MAtrix will help cut down on waste, eliminate manual intervention, and streamline workflows to deliver quicker settlements and better customer experience, the partners said. Anand Roy, MD & CEO, Star Health, said the shift reflects the insurer's intent to build a technology-led, agile claims infrastructure. 'This partnership is a key milestone in our journey to strengthen claims management. By improving speed, accuracy, and consistency, we aim to deliver a transparent and reliable claims service while addressing fraud, waste, and abuse,' he said. Medi Assist CEO Satish Gidugu said the collaboration will modernize claims adjudication and reshape how insurers interact with stakeholders. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trading CFD dengan Teknologi dan Kecepatan Lebih Baik IC Markets Mendaftar Undo 'We are redefining industry standards in technology-driven operations,' he said. The MAtrix platform provides Star Health with a rules-based adjudication engine that improves accuracy and consistency. AI co-pilot features support claims teams in making quicker decisions, while machine learning tools enhance fraud detection. The system's integration with Star Health's internal architecture ensures scale, real-time exchange, and compliance with the National Health Claims Exchange framework. The partnership also brings in AI-powered customer engagement tools such as chatbots and virtual assistants, with omnichannel availability via mobile apps and WhatsApp. These upgrades are expected to improve responsiveness and policyholder satisfaction. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now


Time of India
2 hours ago
- Time of India
Study reveals how 'unhealthy' seed oils can help prevent heart diseases and type 2 diabetes
Image credits: Getty Images The seed of thought that certain 'seed oils' are unhealthy and harmful for the body, has been crushed by a new study to reveal a new oily detail. For years, social media health gurus and nutrition coaches have warned people against using seed oils for cooking, treating it like a toxic product. However, a new study presented at the 2025 annual meeting of the American Society for Nutrition, has crushed that seed to prove that its oil is, on the contrary, very healthy. Linoleic acid is healthy for the body Image credits: Getty Images According to the findings of the study, people with high levels of linoleic acid have a lower risk of heart disease and type 2 diabetes due to reduced inflammation. Linoleic acid is present in seed oils, derived from the seeds of a plant such as sunflower, canola and sesame. Thus, this association completely dissolves the belief that seed oils are "bad" for health. "The study based on almost 1900 people found that higher linoleic acid in blood plasma was associated with lower levels of biomarkers of cardiometabolic risk," said Kevin C. Maki, adjunct professor at the Indiana University School of Public Health-Bloomington in a statement. The study is based on prominent evidence Image credits: Getty Images While these results match with previous research, this study was based on bloodwork and this makes its findings even more prominent than observational evidence. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo The study made the use of objective biomarkers rather than diet records or food frequency questionnaires to assess linoleic acid intake. Additionally, markers of inflammation and indicators of glucose metabolism were also analysed. Maki noted how they tested for other inflammation biomarkers and consistently found that 'people with higher levels of linoleic acid in their blood tended to have a healthier overall risk profile for heart disease and diabetes.' Not just the study, experts as well are adding to the fact that seed oils aren't as unhealthy as proposed. "Seed oils are objectively quite healthy, in that they're typically low in saturated fats,' said Kerry Beeson, a nutritional therapist at Prep Kitchen to NY Post. One step to a healthier you—join Times Health+ Yoga and feel the change
&w=3840&q=100)

Business Standard
2 hours ago
- Business Standard
Sun Pharma partner Philogen withdraws EU application for skin cancer drug
Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback Anjali Singh Mumbai Listen to This Article Sun Pharmaceutical's European partner Philogen S.p.A has voluntarily withdrawn its marketing authorisation application for its investigational skin cancer therapy Nidlegy in the European Union (EU). The decision comes a year after the application was submitted to the European Medicines Agency (EMA) for the treatment of locally advanced, fully resectable melanoma. Analysts believe while this development may not have any immediate financial repercussions for Sun Pharma, it could influence the company's long-term strategic positioning, particularly in the European and Australian markets. 'The timing of this development is also unfavourable for the company, considering the setback earlier this month when another investigational